Boston, July 02, 2025 (GLOBE NEWSWIRE) — According to the latest study from BCC Research, “Clinical Trial Infrastructure Regional Analysis Market: Middle East and North Africa” is expected to reach $1.3 billion by the end of 2029 at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2029.
This report examines the clinical trial markets in the Middle East and North Africa (MENA) region. It covers clinical advances, economic factors, and business considerations, and identifies the market forces affecting different phases, study types, and therapeutic areas. The market is segmented into services, solutions, and supplies, focusing on regional dynamics.
Turkey and Israel are excluded from this report because their clinical trial markets are much more advanced than those of other MENA countries. Including them would have skewed the analysis, making it less relevant for understanding the opportunities and challenges in the rest of the region. This focused approach ensures a more accurate examination of the emerging clinical trial landscape in MENA, which is particularly useful for companies looking to expand into less developed markets.
The factors driving the market’s growth include:
Regulatory Frameworks Driving Trial Feasibility: Regulatory frameworks ensure that clinical trials are conducted ethically and efficiently. In the MENA region, evolving regulatory standards are making it easier to conduct clinical trials by providing clear guidelines and faster approval processes. This helps minimize potential risks and ensure that trials meet necessary standards and ethical guidelines. These frameworks also build confidence among participants and investigators, leading to better trial outcomes.
Growing Patient Population, Enhancing Recruitment and Diversity: The MENA region has a growing and diverse patient population, which is beneficial for clinical trials. A larger patient pool can enhance recruitment efforts and improve the diversity of trial participants. This diversity is essential for ensuring trial results apply to a broader population, leading to more reliable and generalizable data. It also helps in understanding how different demographic groups respond to treatments.
Technological Advances Streamlining Operations: Technological advances are transforming clinical trial operations. Innovations such as advanced data analytics, artificial intelligence, wearable health devices, and decentralized clinical trials are making trials more efficient and patient-centric. These technologies help in faster data collection and analysis, enable real-time patient monitoring, and reduce the need for frequent on-site visits, lowering operational costs and improving …